Recently, Fu et al. discovered that the ZEB1/p53 axis plays an important role in breast cancer, where the N-terminal zinc finger domain of ZEB1 can bind to p53, catalyze p53 deacetylation, and promote its degradation. Here, ZEB1 is linked to breast carcinoma.